Saturday, January 31, 2026

HLB Therapeutics CEO: New Eye Drop Could Disrupt the Market for Rare Corneal Disease

HLB Therapeutics CEO anticipates RGN-259 could surpass Oxervate within 3 years as a simpler, cost-effective NK treatment.

Cross The Line: US Ally Army Chief Confirms Drone Policy Can Target North Korea

Army Chief Kim Kyu-ha stated military drones may target North Korea if needed, emphasizing adherence to protocols amid controversy.

Tag: dismissal

No posts to display

Top News

- Our Sponsors Ad -

Follow us